文献速递慢病防控与筛查卫生政策与健康促进

2006-2016年美国阿片类药物医疗使用趋势

Trends in Medical Use of Opioids in the U.S., 2006-2016.
PubMed 文献 · Am J Prev Med · 2018-03-15

本研究利用美国缉毒局2006-2016年报告整合系统数据,分析十种阿片类药物按重量及折算吗啡毫克当量的合法调配量。十种阿片类药物总量在2011年达峰值389.5公吨吗啡毫克当量,高于2006年286.1和2016年364.6。2011年后除丁丙诺啡增加75.2%外,多种阿片类药物用量下降。

要点

  • 十种阿片类药物总量2011年达峰389.5公吨吗啡毫克当量,2016年降至364.6。
  • 2011年后氢可酮降28.4%、羟吗啡酮降28.0%、芬太尼降21.4%、吗啡降18.9%、羟考酮降13.8%、哌替啶降58.0%,丁丙诺啡增75.2%。
  • 2016年人均吗啡毫克当量最高州为罗德岛2,623.7 mg/人,最低为北达科他州484.7 mg/人,相差五倍。

核心结论

  • 除用于治疗阿片类药物使用障碍的丁丙诺啡外,美国处方阿片类药物使用在过去5年呈下降趋势。
  • 需进一步努力继续优化急性疼痛适当阿片类药物可及性与减少转用及治疗阿片成瘾之间的平衡。

研究设计与样本

  • 数据来自美国缉毒局报告整合系统2006-2016年,分析十种阿片类药物全国合法调配量按重量及折算吗啡毫克当量。
  • 2017年完成地理空间及州级分析。

主要发现

  • 十种阿片类药物总量2011年达峰389.5公吨吗啡毫克当量,2006年为286.1,2016年为364.6。
  • 2016年较2011年,氢可酮降28.4%,羟吗啡酮降28.0%,芬太尼降21.4%,吗啡降18.9%,羟考酮降13.8%,哌替啶降58.0%,丁丙诺啡增75.2%。
  • 2016年人均吗啡毫克当量最高为罗德岛2,623.7 mg/人,最低为北达科他州484.7 mg/人,相差五倍。
  • 州中位年龄与人均吗啡毫克当量相关(r=0.49,p<0.0005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The U.S. is experiencing an opioid epidemic which is at least partially iatrogenic and fueled by both prescription and illicit misuse. This study provides a nationwide examination of opioid distribution patterns during the last decade. METHODS: Data were obtained from the U.S. Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for 2006-2016. Analyses include quantities of ten opioids legally dispensed nationwide by weight and converted to Morphine Milligram Equivalents. Geospatial and state-level analyses were also completed in 2017. RESULTS: The total for ten opioids peaked in 2011 (389.5 metric tons Morphine Milligram Equivalents) relative to both 2006 (286.1) and 2016 (364.6). Changes in the volume of opioids by weight over the decade were agent specific. Since 2011, there were decreases in hydrocodone (-28.4%); oxymorphone (-28.0%); fentanyl (-21.4%); morphine (-18.9%); oxycodone (-13.8%); and meperidine (-58.0%) and an increase in buprenorphine (75.2%) in 2016. There were substantial inter-state variations in rates with a fivefold difference between the highest Morphine Milligram Equivalents in 2016 (Rhode Island=2,623.7 mg/person) relative to the lowest (North Dakota=484.7 mg/person). An association was identified between state median age and per capita Morphine Milligram Equivalents (r =0.49, p<0.0005). CONCLUSIONS: With the exception of buprenorphine, used to treat an opioid use disorder, prescription opioid use has been decreasing over the past 5 years in the U.S. Further efforts are needed to continue to optimize the balance between appropriate opioid access for acute pain while minimizing diversion and treating opioid addiction.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Piper BJ, Shah DT, Simoyan OM, et al. Trends in Medical Use of Opioids in the U.S., 2006-2016. Am J Prev Med. 2018. PMID: 29551331. doi:10.1016/j.amepre.2018.01.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。